17-47345080-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152347.5(EFCAB13):āc.499C>Gā(p.His167Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,602,540 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152347.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB13 | ENST00000331493.7 | c.499C>G | p.His167Asp | missense_variant | 8/25 | 1 | NM_152347.5 | ENSP00000332111.2 | ||
EFCAB13 | ENST00000517484.5 | c.499C>G | p.His167Asp | missense_variant | 8/22 | 2 | ENSP00000430048.1 | |||
EFCAB13 | ENST00000517310.5 | c.55C>G | p.His19Asp | missense_variant | 9/11 | 2 | ENSP00000466136.1 | |||
EFCAB13 | ENST00000520776.5 | n.633C>G | non_coding_transcript_exon_variant | 6/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000671 AC: 102AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000399 AC: 97AN: 242866Hom.: 0 AF XY: 0.000457 AC XY: 60AN XY: 131314
GnomAD4 exome AF: 0.00120 AC: 1745AN: 1450322Hom.: 3 Cov.: 29 AF XY: 0.00115 AC XY: 830AN XY: 721372
GnomAD4 genome AF: 0.000670 AC: 102AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000658 AC XY: 49AN XY: 74424
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2024 | The c.499C>G (p.H167D) alteration is located in exon 8 (coding exon 5) of the EFCAB13 gene. This alteration results from a C to G substitution at nucleotide position 499, causing the histidine (H) at amino acid position 167 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at